<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36604301</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0325-7541</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>Revista Argentina de microbiologia</Title><ISOAbbreviation>Rev Argent Microbiol</ISOAbbreviation></Journal><ArticleTitle>[Legionnaires' disease in Argentina: Evolution of the laboratory diagnostic strategy].</ArticleTitle><Pagination><StartPage>160</StartPage><EndPage>166</EndPage><MedlinePgn>160-166</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ram.2022.10.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0325-7541(22)00103-1</ELocationID><Abstract><AbstractText>Legionnaires' disease (LD) is severe acute pneumonia that occurs in sporadic or epidemic form, and generally requires hospitalization. The objective of this work was to describe the experience in the LD laboratory diagnostic approach in Argentina during the period 2016-2021. The laboratory analyzed 168 clinical specimens from 93 cases of suspected LD pneumonia. Laboratory tests included the detection of the soluble antigen of Legionella pneumophila serogroup 1 in urine sample, detection of DNA of Legionella spp. in lower respiratory secretions by conventional and commercial molecular methods and isolation in selective medium. LD was confirmed in 12 patients. The urinary antigen allowed the diagnosis for 8 patients. L. pneumophila was isolated from the respiratory material of 6 patients suffering from health care-associated pneumonia, who had been previously diagnosed using the commercial molecular method. Fifty percent of these cases did not show detectable urinary antigen. A single patient did not shows neither detectable antigenuria nor isolation of Legionella from the respiratory sample and was diagnosed as a confirmed case of LD by the detection of DNA of Legionella spp. by PCR directly from the respiratory secretion and the epidemiological link with another case of confirmed LD by culture. Urinary antigen detection is the first-line diagnostic test. However, the incorporation of complementary molecular methods has proved to avoid false negatives and contributed to a better understanding of the true incidence of the disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Asociaci&#xf3;n Argentina de Microbiolog&#xed;a. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cipolla</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbr&#xe1;n, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Florencia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbr&#xe1;n, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armitano</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbr&#xe1;n, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbr&#xe1;n, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto</LastName><ForeName>M&#xf3;nica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos Malbr&#xe1;n, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina. Electronic address: pmaprieto@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Enfermedad del legionario en Argentina: evoluci&#xf3;n de la estrategia diagn&#xf3;stica en el laboratorio.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Rev Argent Microbiol</MedlineTA><NlmUniqueID>8002834</NlmUniqueID><ISSNLinking>0325-7541</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007877" MajorTopicYN="Y">Legionnaires' Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016952" MajorTopicYN="Y">Legionella pneumophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atypical pneumonia</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico sindr&#xf3;mico</Keyword><Keyword MajorTopicYN="N">Enfermedad del legionario</Keyword><Keyword MajorTopicYN="N">Legionellosis</Keyword><Keyword MajorTopicYN="N">Legionelosis</Keyword><Keyword MajorTopicYN="N">Legionnaires&#x2019; disease</Keyword><Keyword MajorTopicYN="N">Neumon&#xed;a at&#xed;pica</Keyword><Keyword MajorTopicYN="N">Syndromic diagnosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>21</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36604301</ArticleId><ArticleId IdType="doi">10.1016/j.ram.2022.10.001</ArticleId><ArticleId IdType="pii">S0325-7541(22)00103-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>